Table 1 Clinical Characteristics of the patient cohort
Characteristics | MCC (N = 18) | BCC (N = 3) | SCC (N = 3) |
|---|---|---|---|
Sex | |||
 Female | 7 | 2 | 2 |
 Male | 4 | 1 | 1 |
mean (SD)[range] years | |||
 Total | 72.06 (12.24) [41–93] | 79 (7.21) [73–87] | 78.3 (4.04) [74–82] |
 Female | 71.77 (12.93) [41–93] | 82 (7.07) [77–87] | 80.5 (2.12) [79–82] |
Localization | |||
 Head and/or Neck | 2/18 (11%) | 2/3 (66.6%) | 3/3 (100%) |
 Trunk | 1/18 (5.5%) | 1/3 (33%) |  |
 Extremities | 15/18 (83%) |  |  |
MCPyV expression | |||
 Positive | 17/18 (94.4%) | 1/3 (trace level T-ag) |  |
 Negative | 1/18 (5.5%) | 2/3 (66.6%) | 3/3 (100%) |
Stage AJCC (2019) | |||
 I | 2/18 (11.1%) | 3/3 (100%) | 3/3 (100%) |
 IIA | 4/18 (22.2%) |  |  |
 IIB | 1/18 (5.5%) |  |  |
 IIIB | 1/18 (5.5%) |  |  |
 IV | 10/18 (60%) |  |  |
Current Status | |||
 Dead | 9/11 (82%) |  |  |
 Alive | 2/11 (18%) | 3/3 (100%) | 3/3 (100%) |